The Fasting Mimicking Diet - Learn how to incorporate fasting into your practice
The Fasting Mimicking Diet (FMD) has been shown in a clinical trial to reduce risk factors for metabolic syndrome and other age-related diseases. There are over 20 trials on FMD underway or completed for diabetes, metabolic syndrome, PCOS, infertility, depression, ulcerative colitis, obesity, cancer support, poor immunity, and for reduction of biomarkers of chronic disease.
Intermittent fasting diets are the most popular diets searched for online. Healthcare practitioners need to know the mechanism of action and medical benefits of fasting and intermittent fasting diets to provide patients with informed guidance. Strategic use of intermittent fasting has significant benefits, and it is simple to administer and incorporate into clinical practice.
FMD has been shown in mice to lower IGF-1, extend longevity, lower visceral fat, reduce cancer incidence, and modulate the immune system in mice. Re-feeding was associated with elevated number of stem cells and of tissue regeneration. FMD was shown to promote hippocampal neurogenesis and cognitive performance.Five days of FMD is required to achieve autophagy. Autophagy is the natural process of recycling old cells or cellular debris.
This webinar presents a unique opportunity to stay ahead of scientific breakthroughs in the fasting field, followed by a Q&A session.
- Tuesday 8 March
- Time: 6.30-8.00 pm Australian Eastern Daylight Time (AEDT)